Alastair joins DirectorsTalk to discuss its latest positive update on our rapid SARS-Cov-2 antigen test and neutralising therapy, after the recent announcement of progress with Cytiva.
Alastair joins DirectorsTalk to discuss its latest positive update on our rapid SARS-Cov-2 antigen test and neutralising therapy, after the recent announcement of progress with Cytiva.